NYSE: FMCFmc Corp Stock
$37.46+0.16 (+0.43%)
Updated Aug 15, 2025
FMC Price
$37.46
Fair Value Price
N/A
Market Cap
$4.68B
52 Week Low
$32.83
52 Week High
$67.75
P/E
46.25x
P/B
1.06x
P/S
1.26x
PEG
0.43x
Dividend Yield
6.19%
Revenue
$4.13B
Earnings
$99.90M
Gross Margin
39.6%
Operating Margin
12.18%
Profit Margin
2.4%
Debt to Equity
1.79
Operating Cash Flow
$32M
Beta
0.82
Next Earnings
N/A
Ex-Dividend
Sep 30, 2025
Next Dividend
Oct 16, 2025
FMC Overview
FMC Corporation is a chemical manufacturer. Offerings include insecticides, herbicides, fungicides, biologicals, crop nutrition, and seed treatment products to enhance crop yield and quality by controlling a range of insects, weeds, and diseases. FMC was founded in 1883 and is headquartered in Philadelphia, PA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FMC's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Agricultural Input
Industry Rating
A
FMC
Ranked#9 of 12
Ranked#9 of 12
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $91.28 | A | |
| $57.13 | A | |
| $62.17 | B |
Be the first to know about important FMC news, forecast changes, insider trades & much more!
FMC News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FMC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FMC ($37.46) is trading above its intrinsic value of $36.52, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FMC is poor value based on its earnings relative to its share price (46.25x), compared to the US market average (35.99x)
P/E vs Market Valuation
FMC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more FMC due diligence checks available for Premium users.
Valuation
FMC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
46.25x
Industry
26.82x
Market
35.99x
FMC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FMC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
FMC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.06x
Industry
1.48x
FMC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FMC price to earnings growth (PEG)
For valuing profitable companies with growth potential
FMC is good value based... subscribe to Premium to read more.
PEG Value Valuation
FMC's financial health
Profit margin
Revenue
$1.1B
Net Income
$66.7M
Profit Margin
6.3%
FMC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FMC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.3B
Liabilities
$7.9B
Debt to equity
1.79
FMC's short-term assets ($5.47B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FMC's short-term assets ($5.47B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FMC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FMC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$49.5M
Investing
-$13.4M
Financing
$76.6M
FMC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FMC vs Agricultural Input Stocks
Fmc Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.